COPENHAGEN, Denmark — August 27, 2025 — Leads & Copy — Adcendo, a clinical-stage biotech company, will participate in five investor conferences in September. The company will attend the Citi 2025 Biopharma Back-to-School Conference in Boston on September 2 for one-on-one meetings.
Adcendo will also present at the Wells Fargo 2025 Healthcare Conference in Boston on September 3 at 3:45 p.m. ET and participate in one-on-one meetings at the Cantor Global Healthcare Conference in New York on September 4.
Additionally, the company will present at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 8 at 1:50 p.m. ET and attend the Bank of America Healthcare Trailblazers Private Company Conference in Boston on September 17 for one-on-one meetings.
Adcendo is developing antibody-drug conjugates (ADCs) for cancers with high unmet medical needs.
For more information, visit www.adcendo.com.
Source: Adcendo
